Dr. Roma Mukesh Mehta, MD

Dr. Mehta practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Dr. Mehta's NPI, 1467895938, was assigned on April 15, 2013. Dr. Mehta graduated from University of Miami, Miller School of Medicine in 2013. Dr. Mehta's Texas license number on file is Q9445.

Dr. Mehta's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Dr. Mehta's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dr. Mehta is also affiliated with UAB Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Mehta to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Mehta is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Mehta has a license on file in Texas.

Dmand AI lists chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pneumonia and respiratory infection and sepsis among the conditions Dr. Mehta treats.

CMS data shows 389 Medicare services from Dr. Mehta across 3 procedure codes in 2024, for 162 Medicare patients. Medicare paid $55,128 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 162 Medicare patients who saw Dr. Mehta in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 3.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 68, with 58% women.

In 2024, Dr. Mehta wrote 40 Medicare Part D claims for 13 patients. 85% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $3,517 in total drug cost. In 2022, CMS named 237 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Mehta for performance year 2024, reported as part of a group. Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Mehta in 2023. Dr. Mehta's most frequent co-authors are Jeremy Yan-Shun Chow, MD, Arturo Ricardo Dominguez, MD and Carolee Dawnielle Estelle, MD.

CMS Open Payments shows 34 general payments to Dr. Mehta from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $284.

Dr. Mehta graduated from University of Miami, Miller School of Medicine in 2013.

Dr. Mehta is in network with 20 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.